The American Heart Association will broadcast LIVE from the 2016 Scientific Sessions, to discuss a study that seeks to understand what the optimal dose of aspirin is for patients with heart disease. Dr. Matthew Roe, lead investigator and patient participant Ken Grigoire will answer YOUR questions about the clinical research study that was created to find the answer.
The ADAPTABLE study is being presented to fellow clinicians, researchers and scientists attending Scientific Sessions, Nov. 12th – Nov 16th in New Orleans. #AHA16 is the leading cardiovascular meeting in the country with more than 17,000 professionals attending annually. The scientific programming is designed to improve patient care by providing a forum for researchers and scientists to share significant advances in prevention, diagnosis and treatment of cardiovascular disease from different perspectives. www.scientificsessions.org.
Join us for the LIVE Q&A, shared here on this event page, on the @AmericanHeart page or from @healthinourhandsnetwork
The ADAPTABLE study is funded through a Patient-Centered Outcomes Research Institute (PCORI) Award.
More
Less
